90 results on '"Cunha, Jm"'
Search Results
2. Abnormal Eye and Cranial Movements Triggered by Examination in People with Functional Neurological Disorder
- Author
-
Teodoro, T, Cunha, JM, Abreu, LF, Yogarajah, M, and Edwards, MJJ
- Subjects
sense organs - Abstract
The diagnosis of functional neurological disorder (FND) relies on the demonstration of positive symptoms and signs, as supported by recent changes in DSM5. We recorded the findings of routine clinical eye movement assessment in 101 consecutive new patients with FND. Clinical examination triggered facial and eye movement disorders in 46% of patients, all with positive characteristics of functional movement disorder. These are useful as supporting features in making a positive diagnosis of FND.
- Published
- 2018
3. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?
- Author
-
Fernandes, Jf, Rocha, V, Labopin, M, Neven, B, Moshous, D, Gennery, Ar, Friedrich, W, Porta, F, Diaz de Heredia, C, Wall, D, Bertrand, Y, Veys, P, Slatter, M, Schulz, A, Chan, Kw, Grimley, M, Ayas, M, Gungor, T, Ebell, W, Bonfim, C, Kalwak, K, Taupin, P, Blanche, S, Gaspar, Hb, Landais, P, Fischer, A, Gluckman, E, Cavazzana Calvo, M, Eurocord, Inborn Errors Working Party of European Group for Blood, Marrow Transplantation: Ahmed, A, Auiti, A, Biffi, A, Cant, A, Fasth, A, Gennery, A, Hassan, A, Lankester, A, O'Mera, A, Plabani, A, Rovelli, A, Salmon, A, Scarselli, A, Thrasher, A, Van Royen, A, Villa, A, Wawer, A, Wahadneh, A, Worth, A, Belohradsky, B, Wolska, B, Gaspar, B, Bonfirm, C, Booth, C, Klein, C, Messina, C, Peters, C, Steward, C, Lindemans, C, Schuetz, C, de Heredia Rubio CD, Bensoussan, D, Gleadow, D, Lilic, D, Gambineri, Eleonora, Smith, E, Aerts, F, Caracseghi, F, Roberts, G, Davies, G, Al Mousa, H, Jossanc, H, Ozsahim, H, Hirsch, I, Meyts, I, Tezcan, I, Mueller, I, Andresc, I, Boelens, J, Fernandes, J, Folloni, J, Keuhl, J, Reichenbach, J, Stary, J, Wachowiak, J, Xu Bayford, J, Cunha, Jm, Ehlert, J, Rao, K, Sykora, K, Andais, L, Brown, L, Dal Cortivo, L, Griffith, L, Notarangelo, L, Abinun, M, Albert, M, Bierings, M, Bouchet, M, Cavazzana, M, Hirschfield, M, Cowan, M, Hoenig, M, Loubser, M, Roncarolo, M, Sauer, M, Schneider, M, Verstegen, M, Schroeder, M, Essink, M, Yesilipek, M, Entz Werle, N, Mahlaoui, N, Schlautmann, N, Taylor, N, Vanroyen, N, Walffraat, N, Sanal, O, Amrolia, P, Bordigoni, P, De Coppi, P, Frange, P, Orchard, P, Sedlacek, P, Shaw, P, Stephensky, P, Bacchetta, R, Bredius, R, Formankova, R, Gale, R, Seger, R, Wynn, R, Corbacioglu, S, Ehl, S, Hacein Bey, S, Hambleton, S, Mohsen, S, Mueller, S, Pai, Sy, Espanol, T, Flood, T, Guengoer, T, Bordon, V, Ormoor, V, Pashano, V, Courteille, V, Czogala, W, Qasim, W, Camci, Y, and Nademi, Z.
- Subjects
Male ,medicine.medical_specialty ,Transplantation Conditioning ,medicine.medical_treatment ,Immunology ,Graft vs Host Disease ,Kaplan-Meier Estimate ,Cord Blood Stem Cell Transplantation ,Hematopoietic stem cell transplantation ,Biochemistry ,Gastroenterology ,SCID HSCT ,Internal medicine ,medicine ,Humans ,Proportional Hazards Models ,Retrospective Studies ,Preparative Regimen ,Severe combined immunodeficiency ,business.industry ,Umbilical Cord Blood Transplantation ,Incidence ,Hematopoietic Stem Cell Transplantation ,Infant, Newborn ,Infant ,Cell Biology ,Hematology ,medicine.disease ,Surgery ,Transplantation ,Treatment Outcome ,Child, Preschool ,Histocompatibility ,Cord blood ,Female ,Severe Combined Immunodeficiency ,business - Abstract
Pediatric patients with SCID constitute medical emergencies. In the absence of an HLA-identical hematopoietic stem cell (HSC) donor, mismatched related-donor transplantation (MMRDT) or unrelated-donor umbilical cord blood transplantation (UCBT) are valuable treatment options. To help transplantation centers choose the best treatment option, we retrospectively compared outcomes after 175 MMRDTs and 74 UCBTs in patients with SCID or Omenn syndrome. Median follow-up time was 83 months and 58 months for UCBT and MMRDT, respectively. Most UCB recipients received a myeloablative conditioning regimen; most MMRDT recipients did not. UCB recipients presented a higher frequency of complete donor chimerism (P = .04) and faster total lymphocyte count recovery (P = .04) without any statistically significance with the preparative regimen they received. The MMRDT and UCBT groups did not differ in terms of T-cell engraftment, CD4+ and CD3+ cell recoveries, while Ig replacement therapy was discontinued sooner after UCBT (adjusted P = .02). There was a trend toward a greater incidence of grades II-IV acute GVHD (P = .06) and more chronic GVHD (P = .03) after UCBT. The estimated 5-year overall survival rates were 62% ± 4% after MMRDT and 57% ± 6% after UCBT. For children with SCID and no HLA-identical sibling donor, both UCBT and MMRDT represent available HSC sources for transplantation with quite similar outcomes.
- Published
- 2012
4. Effect of blood components, abdominal distension, and ecdysone therapy on the ultrastructural organization of posterior midgut epithelial cells and perimicrovillar membranes in Rhodnius prolixus
- Author
-
Albuquerque-Cunha, JM, primary, Mello, CB, additional, Garcia, ES, additional, Azambuja, P, additional, Souza, W de, additional, Gonzalez, MS, additional, and Nogueira, NFS, additional
- Published
- 2004
- Full Text
- View/download PDF
5. The nurse in sexual abuse child suspicion attention: a phenomenology approach.
- Author
-
Ciuffo LL, Rodrigues BMR, and da Cunha JM
- Abstract
Copyright of Online Brazilian Journal of Nursing is the property of Fundacao Euclides da Cunha de Apoio Institucional a UFF and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
- Full Text
- View/download PDF
6. Early evidence of beneficial and protective effects of Protectin DX treatment on behavior responses and type-1 diabetes mellitus related-parameters: A non-clinical approach.
- Author
-
Waltrick APF, Radulski DR, de Oliveira KM, Acco A, Verri WA, da Cunha JM, and Zanoveli JM
- Subjects
- Animals, Male, Rats, Depression drug therapy, Depression etiology, Antioxidants pharmacology, Antioxidants therapeutic use, Hyperalgesia drug therapy, Behavior, Animal drug effects, Hippocampus drug effects, Hippocampus metabolism, Prefrontal Cortex drug effects, Diabetic Neuropathies drug therapy, Rats, Wistar, Diabetes Mellitus, Experimental complications, Diabetes Mellitus, Experimental drug therapy, Diabetes Mellitus, Experimental psychology, Diabetes Mellitus, Type 1 drug therapy, Diabetes Mellitus, Type 1 complications, Diabetes Mellitus, Type 1 psychology, Docosahexaenoic Acids pharmacology, Docosahexaenoic Acids therapeutic use, Anxiety drug therapy, Anxiety etiology
- Abstract
Protectin DX (PDX), a specialized pro-resolving lipid mediator, presents potential therapeutic applications across various medical conditions due to its anti-inflammatory and antioxidant properties. Since type-1 diabetes mellitus (T1DM) is a disease with an inflammatory and oxidative profile, exploring the use of PDX in addressing T1DM and its associated comorbidities, including diabetic neuropathic pain, depression, and anxiety becomes urgent. Thus, in the current study, after 2 weeks of T1DM induction with streptozotocin (60 mg/kg) in Wistar rats, PDX (1, 3, and 10 ng/animal; i.p. injection of 200 μl/animal) was administered specifically on days 14, 15, 18, 21, 24, and 27 after T1DM induction. We investigated the PDX's effectiveness in alleviating neuropathic pain (mechanical allodynia; experiment 1), anxiety-like and depressive-like behaviors (experiment 2). Also, we studied whether the PDX treatment would induce antioxidant effects in the blood plasma, hippocampus, and prefrontal cortex (experiment 3), brain areas involved in the modulation of emotions. For evaluating mechanical allodynia, animals were repeatedly submitted to the Von Frey test; while for studying anxiety-like responses, animals were submitted to the elevated plus maze (day 26) and open field (day 28) tests. To analyze depressive-like behaviors, the animals were tested in the modified forced swimming test (day 28) immediately after the open field test. Our data demonstrated that PDX consistently increased the mechanical threshold throughout the study at the two highest doses, indicative of antinociceptive effect. Concerning depressive-like and anxiety-like behavior, all PDX doses effectively prevented these behaviors when compared to vehicle-treated T1DM rats. The PDX treatment significantly protected against the increased oxidative stress parameters in blood plasma and in hippocampus and prefrontal cortex. Interestingly, treated animals presented improvement on diabetes-related parameters by promoting weight gain and reducing hyperglycemia in T1DM rats. These findings suggest that PDX improved diabetic neuropathic pain, and induced antidepressant-like and anxiolytic-like effects, in addition to improving parameters related to the diabetic condition. It is worth noting that PDX also presented a protective action demonstrated by its antioxidant effects. To conclude, our findings suggest PDX treatment may be a promising candidate for improving the diabetic condition per se along with highly disabling comorbidities such as diabetic neuropathic pain and emotional disturbances associated with T1DM., Competing Interests: Declaration of competing interest The authors declare no conflicting interests., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
7. A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats.
- Author
-
Lopes MS, Baptistella GB, Nunes GG, Ferreira MV, Cunha JM, Oliveira KM, Acco A, Lopes MLC, Couto Alves A, Valdameri G, Moure VR, Picheth G, Manica GCM, and Rego FGM
- Abstract
Diabetes mellitus (DM) complications are a burden to health care systems due to the associated consequences of poor glycemic control and the side effects of insulin therapy. Recently. adjuvant therapies, such as vanadium compounds, have gained attention due to their potential to improve glucose homeostasis in patients with diabetes. In order to determine the anti-diabetic and antioxidant effects of the oxidovanadium(IV) complex (Et
3 NH)2 [{VO(OH}2 )(ox)2 (µ-ox)] or Vox2), rats with streptozotocin (STZ)-induced diabetes were treated with 30 and 100 mg/kg of Vox2, orally administered for 12 days. Vox2 at 100 mg/kg in association with insulin caused a 3.4 times decrease in blood glucose in STZ rats (424 mg/dL), reaching concentrations similar to those in the normoglycemic animals (126 mg/dL). Compared to insulin alone, the association with Vox2 caused an additional decrease in blood glucose of 39% and 65% at 30 and 100 mg/kg, respectively, and an increased pancreatic GSH levels 2.5 times. Vox2 alone did not cause gastrointestinal discomfort, diarrhea, and hepatic or renal toxicity and was not associated with changes in blood glucose level, lipid profile, or kidney or liver function. Our results highlight the potential of Vox2 in association with insulin in treating diabetes.- Published
- 2024
- Full Text
- View/download PDF
8. Spatial variability of chemical indicators of Amazon agricultural soils through geomultivariate statistics, Brazil.
- Author
-
Martins TS, de Souza FG, Campos MCC, da Cunha JM, Brito WBM, de Lima AFL, de Assis JM, Oliveira IA, de Oliveira FP, and de Brito Filho EG
- Subjects
- Brazil, Agriculture, Forests, Soil, Environmental Monitoring
- Abstract
This work focuses on evaluating the spatial variability of chemical attributes of soils under different agricultural use and native forest, indicating which are the possible indicator attributes of changes in environmental, through the use and management of the soil. The study was carried out in the southern region of the Amazonas state, in an Argissolo Vermelho-Amarelo (Ultisol). Sampling grids were established measuring: 90 m × 70 m with regular soil collection spacing of 10 m for the guarana and forest areas; 90 m × 56 m spaced at 10 m × 8 m for annatto area; and 54 m × 42 m with spacing between points of 6 m for the cupuaçu area, totaling 80 sampling points in each area, with soil samples collected at depths of 0.0-0.05; 0.05-0.10 m and 0.10-0.20 m. The following attributes were determined: pH, Al
3+ , K+ , Ca2+ , Mg2+ , P, H + Al, CEC, V% and m%. Descriptive, geostatistical and multivariate statistical analyzes were performed. The results show that it is possible to state that the descriptive, geostatistical and multivariate statistical techniques were able to identify the difference between the spatial variability of the attributes according to each specific use of individual soils. The multivariate analysis made it possible to select the attributes that most contribute to the variability of these soils, and with that, it was found that the forest showed less spatial variability in the surface layer, with higher reach values by scaled semivariograms., (© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)- Published
- 2023
- Full Text
- View/download PDF
9. Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus .
- Author
-
Chaves YC, Raymundi AM, Waltrick APF, de Souza Crippa JA, Stern CAJ, da Cunha JM, and Zanoveli JM
- Abstract
Objectives: In view of the neuroprotective characteristic of cannabidiol (CBD) and its beneficial action on aversive memory in non-diabetic animals, we aimed to investigate in animals with experimentally induced type-1 diabetes mellitus (T1DM) whether CBD treatment would be able to impair the contextual fear memory consolidation, its generalisation and whether the effect would be lasting. We also investigated the CBD effect on anxiety-like responses., Methods: After T1DM induction, animals received single or more prolonged treatment with CBD and were submitted to the contextual fear conditioning test. As expression of activity-regulated cytoskeletal-associated (Arc) protein is necessary for memory consolidation, we evaluated its expression in the dorsal hippocampus (DH). For evaluating anxiety-related responses, animals were submitted to the elevated plus maze test (EPMT), in which the time and number of entries in the open arms were used as anxiety index., Results: A single injection of CBD impaired the contextual fear memory consolidation and its generalisation, which was evaluated by exposing the animal in a neutral context. This single injection was able to reduce the elevated expression of Arc in the DH from these animals. Interestingly, more prolonged treatment with CBD also impaired the persistence of context-conditioned fear memory and induced an anxiolytic-like effect, as the treated group spent more time in the open arms of the EPMT., Conclusion: CBD interferes with contextual fear memory and the dosage regimen of treatment seems to be important. Moreover, we cannot rule out the involvement of emotional aspects in these processes related to fear memory.
- Published
- 2023
- Full Text
- View/download PDF
10. Accumulation and decomposition of cultural residues of Theobroma grandiflorum, Paullinia cupana, Bixa orellana and forest in the southern region of Amazonas.
- Author
-
Paula EMB, Cunha JM, Campos MCC, Silva DMP, Silva CL, Lima AFL, and Mantovanelli BC
- Subjects
- Bixaceae, Forests, Soil, Plant Leaves chemistry, Cacao, Paullinia
- Abstract
The litter deposited on the soil surface at various stages of decomposition is important for primary productivity that impacts the microbial communities and soil carbon storage. The objective of this study was to evaluate the accumulation and decomposition of cultural residues of Theobroma grandiflorum (Willd. ex. Spreng) Schum, Paullinia cupana (Mart.) Ducke, Bixa orellana L., and forest in the Amazon region. The study was carried out in the São Francisco settlement, Canutama in the south of Amazonas, in a randomized block experimental design, and the treatments consisted of four areas with different crops: 1 - P. cupana; 2 - T. grandiflorum; 3 - B. orellana; 4 - Native woodland area (forest), in time subdivided plots: 7, 15, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, and 330 days after the distribution of the bags in the field, all with four repetitions. To evaluate the contribution and fractions of litter, conical collectors were used in each area, and collections were performed monthly in the period from March 2020 to February 2021. The estimate of the decomposition rate of the litter was done by quantifying the loss of mass, using litter bags, which allow for a direct analysis of the rate of decay over time. The forest and P. cupana environments presented the highest litter production, and greater deposition when compared to environments cultivated with T. grandiflorum and B. orellana. The forest and B. orellana areas showed the highest speed of decomposition, while the opposite situation occurred under T. grandiflorum and P. cupana cultivation.
- Published
- 2023
- Full Text
- View/download PDF
11. Soil chemical attributes in areas under conversion from forest to pasture in southern Brazilian Amazon.
- Author
-
de Lima AFL, Campos MCC, Martins TS, Silva GA, Brito WBM, Dos Santos LAC, de Oliveira IA, and da Cunha JM
- Subjects
- Animals, Cattle, Brazil, Forests, Phosphorus analysis, Poaceae, Soil, Agriculture
- Abstract
The south of the Brazilian Amazon is one of the largest cattle-producing regions in Brazil, however, most of the pastures are in low fertility soils. Thus, cattle breeders compensate for the low production of pastures, increasing the size of the areas, generating more deforestation and burning. These practices increase the chemical degradation process of Amazonian soils, making them increasingly infertile when improperly managed. With this, the objective of the work was to evaluate the impacts caused in the chemical attributes of soils, in areas under forest-to-pasture conversion, in the south of the Brazilian Amazon. The study was carried out in the district of União Bandeirantes, in an area of forest and two areas with pastures (brachiaria and mombaça grass). In the field, soil samples were collected at two depths (0.00-0.10 and 0.10-0.20 m), to carry out chemical analyzes. Further, uni, bi and multivariate statistical analyzes were carried out, besides geostatistical analyzes were carried out to study spatial variability and management zones. The conversion of forest to pasture increased the pH and exchangeable bases levels, reducing the availability of exchangeable aluminum and potential acidity, however, it induces losses of phosphorus and organic carbon from the soil. Among the pasture environments, the mombaça grass area presented higher fertility. Greater spatial variability of chemical attributes was observed in the environment with mombaça grass, indicating greater heterogeneity in the distribution of attributes in the area. We attribute this behavior to the higher grazing intensity and the micro-reliefs in the area that direct the flow of water and nutrients., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
12. Forest-Fruticulture Conversion Alters Soil Traits and Soil Organic Matter Compartments.
- Author
-
Enck BF, Campos MCC, Pereira MG, de Souza FG, Santos OAQ, Diniz YVFG, Martins TS, Cunha JM, Lima AFL, and Souza TAF
- Abstract
Fruticulture in the Amazonian Rainforest is one of the main causes of deforestation, biodiversity loss, and soil erosion. Fruticulture plays a key role in the soil traits and soil organic matter (SOM) compartments by altering the soil ecosystem. Our aim was to assess the influence of Forest-Fruticulture conversion on soil traits, and SOM fractions in Brazil's Legal Amazon. The experiment was carried out in field conditions using four land uses as main treatments: Bixa orellana , Theobroma grandiflorum , Paullinia cupana , and the Amazon Rainforest. The soil physicochemical traits were analyzed using samples that were collected from 0-5, 5-10, and 10-20 cm soil depth by using grids (10 × 10 m) with 36 sampling points. Our results showed that the Fruticulture promoted an increase in bulk density, GMD, aggregate diameter, soil porosity, gravimetric moisture, sand, clay, carbon associated with humic acid, and, the sum of bases (K
+ , Ca2+ , and Mg2+ ), while the Amazon Rainforest showed the highest values of silt, soil P content, SOC, p-SOC, m-SOC, carbon associated with fulvic acid, humine, and soil C stock. Overall, the fruticulture farming systems have negative effects on SOM compartments. The results of our study highlight the importance of considering fruticulture with endemic plant species by promoting soil fertility and soil aggregation.- Published
- 2022
- Full Text
- View/download PDF
13. Heteroleptic oxidovanadium(IV)-malate complex improves glucose uptake in HepG2 and enhances insulin action in streptozotocin-induced diabetic rats.
- Author
-
de Nigro TP, Manica GCM, de Souza SW, Jesus CHA, Bottini RCR, Missina JM, Valdameri G, Nunes GG, da Cunha JM, Picheth G, and Rego FGM
- Subjects
- Animals, Blood Glucose metabolism, Humans, Hypoglycemic Agents adverse effects, Insulin metabolism, Insulin pharmacology, Malates, Male, Rats, Rats, Wistar, Streptozocin, Vanadates chemistry, Vanadium chemistry, Vanadium pharmacology, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental drug therapy
- Abstract
Diabetes mellitus, a complex and heterogeneous disease associated with hyperglycemia, is a leading cause of mortality and reduces life expectancy. Vanadium complexes have been studied for the treatment of diabetes. The effect of complex [VO(bpy)(mal)]·H
2 O (complex A) was evaluated in a human hepatocarcinoma (HepG2) cell line and in streptozotocin (STZ)-induced diabetic male Wistar rats conditioned in seven groups with different treatments (n = 10 animals per group). Electron paramagnetic resonance and51 V NMR analyses of complex A in high-glucose Dulbecco's Modified Eagle Medium (DMEM) revealed the oxidation and hydrolysis of the oxidovanadium(IV) complex over a period of 24 h at 37 °C to give low-nuclearity vanadates "V1" (H2 VO4 - ), "V2" (H2 V2 O7 2- ), and "V4" (V4 O12 4- ). In HepG2 cells, complex A exhibited low cytotoxic effects at concentrations 2.5 to 7.5 μmol L-1 (IC50 10.53 μmol L-1 ) and increased glucose uptake (2-NBDG) up to 93%, an effect similar to insulin. In STZ-induced diabetic rats, complex A at 10 and 30 mg kg-1 administered by oral gavage for 12 days did not affect the animals, suggesting low toxicity or metabolic impairment during the experimental period. Compared to insulin treatment alone, complex A (30 mg kg-1 ) in association with insulin was found to improve glycemia (30.6 ± 6.3 mmol L-1 vs. 21.1 ± 8.6 mmol L-1 , respectively; p = 0.002), resulting in approximately 30% additional reduction in glycemia. The insulin-enhancing effect of complex A was associated with low toxicity and was achieved via oral administration, suggesting the potential of complex A as a promising candidate for the adjuvant treatment of diabetes., (© 2022. The Author(s), under exclusive licence to Springer Nature B.V.)- Published
- 2022
- Full Text
- View/download PDF
14. Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model.
- Author
-
Leão FF, Waltrick APF, Verri WA Jr, da Cunha JM, and Zanoveli JM
- Subjects
- Animals, Anxiety drug therapy, Behavior, Animal, Cytokines, Depression drug therapy, Depression etiology, Disease Models, Animal, Docosahexaenoic Acids, Hippocampus, Rats, Diabetes Mellitus, Type 1 drug therapy
- Abstract
Type 1 diabetes mellitus (T1DM) is a chronic disease related to a persistent inflammatory process reaching the central nervous system, which leads to psychiatric comorbidities such as depression and anxiety. The search for new therapeutic agents effective in alleviating the psychiatric condition associated with T1DM becomes critical. Using an animal model of T1DM, we aimed to evaluate the effect of a specific specialized pro-resolving lipid mediator Resolvin D5 (RvD5), in preventing behaviors related to depression and anxiety, investigating its influence on inflammasome in interleukin (IL)-1β in the hippocampus and prefrontal cortex. After experimental T1DM induction with streptozotocin (60 mg/kg, i.p.), these animals were treated for 23 days and randomly divided into 6 subgroups according to the treatment: vehicle (VEH), the antidepressant Fluoxetine (FLX; 10 mg/kg), the nonsteroidal anti-inflammatory Ibuprofen (IBU; 30 mg/kg) or Resolvin D5 (RvD5; 1 3, or 10 ng/animal). As a control group for the experimental-T1DM condition, a group of normoglycemic animals treated with VEH underwent the same behavioral tests: elevated plus maze, open field, and modified forced swimming tests. In the end, hippocampus and prefrontal cortex samples were processed to analyze the pro-inflammatory cytokine IL-1β levels. Our data showed that RvD5 treatment prevented the more pronounced anxious-like and reduced the depressive-like behaviors of experimental-T1DM animals and significantly improved the plasma glucose levels. Additionally, RvD5 treatment prevented the increased level of pro-inflammatory cytokine IL-1β in the hippocampus and prefrontal cortex of experimental-T1DM rats. To conclude, RvD5 presents a preventive therapeutic potential in impairing the development of the emotional complications resulting from T1DM. This potential may be related to its protective profile, as demonstrated in this study by its pro-resolutive action on neuroinflammation in the hippocampus and prefrontal cortex., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
15. Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release.
- Author
-
Fattori V, Zaninelli TH, Ferraz CR, Brasil-Silva L, Borghi SM, Cunha JM, Chichorro JG, Casagrande R, and Verri WA Jr
- Subjects
- Analgesics pharmacology, Animals, Calcitonin Gene-Related Peptide metabolism, Cytokines pharmacology, Docosahexaenoic Acids, Hyperalgesia, Lipopolysaccharides pharmacology, Mice, Monocytes metabolism, Neurons, Neutrophils, Nociceptors metabolism, Pain, TRPA1 Cation Channel, TRPV Cation Channels, Capsaicin pharmacology, Transient Receptor Potential Channels
- Abstract
Maresin-2 (MaR2) is a specialized pro-resolution lipid mediator (SPM) that reduces neutrophil recruitment in zymosan peritonitis. Here, we investigated the analgesic effect of MaR2 and its mechanisms in different mouse models of pain. For that, we used the lipopolysaccharide (LPS)-induced mechanical hyperalgesia (electronic version of the von Frey filaments), thermal hyperalgesia (hot plate test) and weight distribution (static weight bearing), as well as the spontaneous pain models induced by capsaicin (TRPV1 agonist) or AITC (TRPA1 agonist). Immune cell recruitment was determined by immunofluorescence and flow cytometry while changes in the pro-inflammatory mediator landscape were determined using a proteome profiler kit and ELISA after LPS injection. MaR2 treatment was also performed in cultured DRG neurons stimulated with capsaicin or AITC in the presence or absence of LPS. The effect of MaR2 on TRVP1- and TRPA1-dependent CGRP release by cultured DRG neurons was determined by EIA. MaR2 inhibited LPS-induced inflammatory pain and changes in the cytokine landscape as per cytokine array assay. MaR2 also inhibited TRPV1 and TRPA1 activation as observed by a reduction in calcium influx in cultured DRG neurons, and the number of flinches and time spent licking the paw induced by capsaicin or AITC. In corroboration, MaR2 reduced capsaicin- and AITC-induced CGRP release by cultured DRG neurons and immune cell recruitment to the paw skin close the CGRP
+ fibers. In conclusion, we show that MaR2 is an analgesic SPM that acts by targeting leukocyte recruitment, nociceptor TRPV1 and TRPA1 activation, and CGRP release in mice., (Copyright © 2022 Elsevier Ltd. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
16. Ecdysone modulates both ultrastructural arrangement of hindgut and attachment of Trypanosoma cruzi DM 28c to the rectum cuticle of Rhodnius prolixus fifth-instar nymph.
- Author
-
Mendonça Lopes D D, Provençano AF AF, Mello CB CB, Feder D D, Albuquerque Cunha JMA JM, Sant'Anna NF NF, Curty Lechuga G GC, Cabral Bourguignon S SC, de Souza W W, de Souza Garcia E ES, Folly E EC, Azambuja P P, and Gonzalez MS MS
- Subjects
- Animals, Ecdysone pharmacology, Nymph, Rectum parasitology, Rectum ultrastructure, Chagas Disease drug therapy, Rhodnius parasitology, Trypanosoma cruzi
- Abstract
Studies on the effects of azadirachtin treatment, ecdysone supplementation and ecdysone therapy on both the ultrastructural organization of the rectum in 5th-instar nymph of Rhodnius prolixus and the ex vivo attachment behavior of Trypanosoma cruzi under these experimental conditions were carried out. Control insects had a typical and significant organization of the rectum cuticle consisted of four main layers (procuticle, inner epicuticle, outer epicuticle, and wax layer) during the entire period of the experiment. Both azadirachtin treatment and ecdysone supplementation avoid the development of both outer epicuticle and wax layer. Oral therapy with ecdysone partially reversed the altered organization and induce the development of the four main rectal cuticle layers. In the same way, the ex vivo attachment of T. cruzi to rectal cuticle was blocked by azadirachtin treatment but ecdysone therapy also partially recovered the parasite adhesion rates to almost those detected in control insects. These results point out that ecdysone may be a factor responsible - directly or indirectly - by the modulation of rectum ultrastructural arrangement providing a superficial wax layer to the attachment followed by metacyclogenesis of T. cruzi in the rectum of its invertebrate hosts., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats.
- Author
-
Gonçalves MR, da Conceição MS, Jesus CHA, Gasparin AT, Rosa ES, and da Cunha JM
- Subjects
- Animals, Cannabinoid Receptor Agonists pharmacology, Hyperalgesia drug therapy, Rats, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Streptozocin pharmacology, Streptozocin therapeutic use, Cannabinoids pharmacology, Cannabinoids therapeutic use, Diabetes Mellitus, Experimental complications, Diabetes Mellitus, Experimental drug therapy
- Abstract
Diabetes is a chronic disease associated with a high number of complications such as peripheral neuropathy, which causes sensorial disturbances and may lead to the development of diabetic neuropathic pain (DNP). The current treatment for DNP is just palliative and the drugs may cause severe adverse effects, leading to discontinuation of treatment. Thus, new therapeutic targets need to be urgently investigated. Studies have shown that cannabinoids have promising effects in the treatment of several pathological conditions, including chronic pain. Thus, we aimed to investigate the acute effect of the intrathecal injection of CB1 or CB2 cannabinoid receptor agonists N-(2-chloroethyl)-5Z, 8Z, 11Z, 14Z-eicosatetraenamide (ACEA) or JWH 133, respectively (10, 30 or 100 μg/rat) on the mechanical allodynia associated with experimental diabetes induced by streptozotocin (60 mg/kg; intraperitoneal) in rats. Cannabinoid receptor antagonists CB1 AM251 or CB2 AM630 (1 mg/kg) were given before treatment with respective agonists to confirm the involvement of cannabinoid CB1 or CB2 receptors. Rats with diabetes exhibited a significant reduction on the paw mechanical threshold 2 weeks after diabetes induction, having the maximum effect observed 4 weeks after the streptozotocin injection. This mechanical allodynia was significantly improved by intrathecal treatment with ACEA or JWH 133 (only at the higher dose of 100 μg). Pre-treatment with AM251 or AM630 significantly reverted the anti-allodynic effect of the ACEA or JWH 133, respectively. Considering the clinical challenge that the treatment of DPN represents, this study showed for the first time, that the intrathecal cannabinoid receptors agonists may represent an alternative for the treatment of DNP., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
18. Physical soil attributes in areas under forest/pasture conversion in northern Rondônia, Brazil.
- Author
-
de Lima AFL, Campos MCC, Enck BF, da Silva Simões W, de Araújo RM, Dos Santos LAC, and da Cunha JM
- Subjects
- Brazil, Environmental Monitoring, Forests, Carbon, Soil
- Abstract
The main cause of physical degradation in pasture areas is overgrazing, and when combined with poorly productive soils, it causes the loss of millions of hectares of agricultural soils a year. Thus, work is needed to indicate which physical attributes are most sensitive to degradation, generating information so that soil management can be proposed, with a view to economic, social, and environmental aspects. Therefore, the objective of the work was to evaluate the impacts caused on the physical attributes of the soil, in forests converted to pastures in northern Rondônia, Brazil. The study was carried out in three areas within the municipality of Porto Velho, Rondônia, one area with forest and two with pastures (brachiaria and mombaça grass). In the field, deformed soil samples were collected at a depth of 0.00-0.10 and 0.10-0.20 m in the three study areas. In the laboratory, physical analyses of texture, aggregates and porosity, compaction, and an additional analysis of soil organic carbon were carried out. Then, univariate, bivariate, and multivariate analyses were performed, as well as geostatistical analysis. The conversion of forest to pasture had a negative impact on aggregates, compaction, porosity, and accumulation of organic carbon in the soil. The studied environments are influenced by the high levels of sand and clay, which interfere in the aggregation, compaction, porosity, and accumulation of organic carbon in the soil. We observed greater spatial variability of physical attributes in the environment with mombaça grass and attributed this to the greater grazing and trampling intensity of the animals., (© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
- Published
- 2021
- Full Text
- View/download PDF
19. Perspectives on the Role of Enzymatic Biocatalysis for the Degradation of Plastic PET.
- Author
-
Magalhães RP, Cunha JM, and Sousa SF
- Subjects
- Biocatalysis, Biodegradation, Environmental, Enzymes chemistry, Protein Engineering, Enzymes metabolism, Plastics analysis, Polyethylene Terephthalates analysis
- Abstract
Plastics are highly durable and widely used materials. Current methodologies of plastic degradation, elimination, and recycling are flawed. In recent years, biodegradation (the usage of microorganisms for material recycling) has grown as a valid alternative to previously used methods. The evolution of bioengineering techniques and the discovery of novel microorganisms and enzymes with degradation ability have been key. One of the most produced plastics is PET, a long chain polymer of terephthalic acid (TPA) and ethylene glycol (EG) repeating monomers. Many enzymes with PET degradation activity have been discovered, characterized, and engineered in the last few years. However, classification and integrated knowledge of these enzymes are not trivial. Therefore, in this work we present a summary of currently known PET degrading enzymes, focusing on their structural and activity characteristics, and summarizing engineering efforts to improve activity. Although several high potential enzymes have been discovered, further efforts to improve activity and thermal stability are necessary.
- Published
- 2021
- Full Text
- View/download PDF
20. Bixin attenuates mechanical allodynia, anxious and depressive-like behaviors associated with experimental diabetes counteracting oxidative stress and glycated hemoglobin.
- Author
-
Gasparin AT, Rosa ES, Jesus CHA, Guiloski IC, da Silva de Assis HC, Beltrame OC, Dittrich RL, Pacheco SDG, Zanoveli JM, and da Cunha JM
- Subjects
- Animals, Antioxidants pharmacology, Anxiety drug therapy, Carotenoids metabolism, Depression drug therapy, Diabetes Mellitus, Experimental physiopathology, Disease Models, Animal, Glutathione pharmacology, Glycated Hemoglobin drug effects, Glycated Hemoglobin metabolism, Hippocampus metabolism, Hyperalgesia metabolism, Hyperglycemia, Lipid Peroxidation, Male, Neuralgia drug therapy, Oxidative Stress drug effects, Oxidative Stress physiology, Rats, Rats, Wistar, Sciatic Nerve metabolism, Streptozocin pharmacology, Carotenoids pharmacology, Hyperalgesia drug therapy
- Abstract
Neuropathic pain, depression, and anxiety are common comorbidities in diabetic patients, whose pathophysiology involves hyperglycemia-induced increased oxidative stress. Bixin (BIX), an apocarotenoid extracted from the seeds of Bixa orellana, has been used in traditional medicine to treat diabetes and has been recognized by its antioxidant profile. We aimed to investigate the effect of the BIX over the mechanical allodynia, depressive, and anxious-like behaviors associated with experimental diabetes, along with its involved mechanisms. Streptozotocin-induced diabetic rats were treated for 17 days (starting 14 days after diabetes induction) with the corresponding vehicle, BIX (10, 30 or 90 mg/kg; p.o), or INS (6 IU; s.c.). Mechanical allodynia, depressive, and anxious-like behavior were assessed by electronic Von Frey, forced swimming, and elevated plus-maze tests, respectively. Locomotor activity was assessed by the open field test. Blood glycated hemoglobin (HbA1) and the levels of lipid peroxidation (LPO) and reduced glutathione (GSH) were evaluated on the hippocampus, pre-frontal cortex, lumbar spinal cord, and sciatic nerve. Diabetic animals developed mechanical allodynia, depressive and anxious-like behavior, increased plasma HbA1, increased LPO, and decreased GSH levels in tissues analyzed. Repeated BIX-treatment (at all tested doses) significantly attenuated mechanical allodynia, the depressive (30 and 90 mg/kg) and, anxious-like behaviors (all doses) in diabetic rats, without changing the locomotor performance. BIX (at all tested doses) restored the oxidative parameters in tissues analyzed and reduced the plasma HbA1. Thereby, bixin may represent an alternative for the treatment of comorbidities associated with diabetes, counteracting oxidative stress and plasma HbA1., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. Exploring three levels of interoception in people with functional motor disorders.
- Author
-
Ricciardi L, Nisticò V, Andrenelli E, Cunha JM, Demartini B, Kirsch LP, Crucianelli L, Yogarajah M, Morgante F, Fotopoulou A, and Edwards MJ
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Conversion Disorder physiopathology, Interoception physiology
- Abstract
Introduction: A three-level model of interoception has recently been defined. We aim to study the interoceptive processing in individuals with functional motor disorder (FMD)., Methods: Twenty-two patients with FMD were compared to 23 healthy controls. They underwent a protocol measuring different levels of interoception including: accuracy (a heart-beat tracking task), awareness (participant's confidence level) and sensibility (the Body Awareness Questionnaire-BAQ). Depression, anxiety and alexithymia were assessed by means of validated clinical scales., Results: The FMD group showed a lower cardiac interoceptive accuracy and sensibility than healthy controls but they did not differ in terms of awareness (p = 0.03 and 0.005 respectively). They were aware of their poor performance in the accuracy task. Cardiac interoceptive accuracy positively correlated with the BAQ sub-scales "Predict Body Reaction" (r = 0.49, p = 0.001) and "Sleep-Wake Cycle" (r = 0.52, p < 0.001). A mediation analysis showed a significant indirect effect of group on cardiac interoceptive accuracy through BAQ "Predict Body Reaction" (b = -2.95, 95% BCa CI[-7.2;-0.2]). The direct effect of group on "Predict Body Reaction" was still significant (b = - 6.95, p = 0.02, 95% CI[-13.18;-0.73])., Conclusions: People with FMD have impaired cardiac interoceptive accuracy and sensibility but no difference in metacognitive interoception compared to healthy controls., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
- Author
-
Chaves YC, Genaro K, Crippa JA, da Cunha JM, and Zanoveli JM
- Subjects
- Animals, Anti-Anxiety Agents pharmacology, Antidepressive Agents pharmacology, Cannabidiol pharmacology, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental psychology, Diabetes Mellitus, Type 1 chemically induced, Diabetes Mellitus, Type 1 psychology, Male, Maze Learning drug effects, Maze Learning physiology, Rats, Rats, Wistar, Receptor, Cannabinoid, CB1 agonists, Receptor, Cannabinoid, CB1 metabolism, Receptor, Serotonin, 5-HT1A metabolism, Anti-Anxiety Agents therapeutic use, Antidepressive Agents therapeutic use, Cannabidiol therapeutic use, Diabetes Mellitus, Experimental drug therapy, Diabetes Mellitus, Type 1 drug therapy
- Abstract
Cannabidiol (CBD), a phytocannabinoid compound, presents antidepressant and anxiolytic-like effects in the type-1 diabetes mellitus(DM1) animal model. Although the underlying mechanism remains unknown, the type-1A serotonin receptor (5-HT1A) and cannabinoids type-1 (CB1) and type-2 (CB2) receptors seem to play a central role in mediating the beneficial effects on emotional responses. We aimed to study the involvement of these receptors on an antidepressant- and anxiolytic-like effects of CBD and on some parameters of the diabetic condition itself. After 2 weeks of the DM1 induction in male Wistar rats by streptozotocin (60 mg/kg; i.p.), animals were treated continuously for 2-weeks with the 5-HT1A receptor antagonist WAY100635 (0.1 mg/kg, i.p.), CB1 antagonist AM251 (1 mg/kg i.p.) or CB2 antagonist AM630 (1 mg/kg i.p.) before the injection of CBD (30 mg/kg, i.p.) or vehicle (VEH, i.p.) and then, they were submitted to the elevated plus-maze and forced swimming tests. Our findings show the continuous treatment with CBD improved all parameters evaluated in these diabetic animals. The previous treatment with the antagonists - 5-HT1A, CB1, or CB2 - blocked the CBD-induced antidepressant-like effect whereas only the blockade of 5-HT1A or CB1 receptors was able to inhibit the CBD-induced anxiolytic-like effect. Regarding glycemic control, only the blockade of CB2 was able to inhibit the beneficial effect of CBD in reducing the glycemia of diabetic animals. These findings indicated a therapeutic potential for CBD in the treatment of depression/anxiety associated with diabetes pointing out a complex intrinsic mechanism in which 5-HT1A, CB1, and/or CB2 receptors are differently recruited.
- Published
- 2021
- Full Text
- View/download PDF
23. Postveraison Deficit Irrigation Effects on Fruit Quality and Yield of "Flame Seedless" Table Grape Cultivated under Greenhouse and Net.
- Author
-
Pinillos V, Ibáñez S, Cunha JM, Hueso JJ, and Cuevas J
- Abstract
Lack of color in the skin of red table grape varieties is a serious problem in areas of warm climate. This problem is often addressed by the application of ethylene release products such as ethephon. Strict regulation in the use of this product in EU forces European grape producers to look for suitable alternatives. With the aim to increase red skin color, we applied regulated deficit irrigation (RDI) strategies from veraison until harvest on "Flame Seedless" table grape vines cultivated under nets and under a plastic greenhouse in South East Spain, and compared yield and fruit quality with vines fully irrigated under the same net and plastic greenhouses. Our results show a modest improvement in the percentage of commercial clusters with better skin color, probably because the short duration of the deficit irrigation period only caused a slight decrease in soil water content and a mild water stress in RDI vines. Larger differences were observed under the more limiting conditions of the plastic greenhouse for light environment, especially when berry skin color was measured by CIRG (color index of red grape). More noticeable effect of RDI was noted on fruit earliness. Water savings were also remarkable. Negative effects of RDI on berry size or total soluble solid content were not perceived. Our results suggest that RDI is a suitable strategy to save irrigation water without substantial negative effects on yield and berry size. However, the effects on skin color were insufficient in the trial conditions.
- Published
- 2020
- Full Text
- View/download PDF
24. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
- Author
-
Godoi MM, Junior HZ, da Cunha JM, and Zanoveli JM
- Subjects
- Analgesics, Opioid pharmacology, Animals, Arachidonic Acids pharmacology, Behavior, Animal drug effects, Cannabinoid Receptor Agonists pharmacology, Cannabinoid Receptor Antagonists pharmacology, Enkephalin, Ala(2)-MePhe(4)-Gly(5)- pharmacology, Excitatory Amino Acid Agonists pharmacology, Freezing Reaction, Cataleptic drug effects, Male, Microinjections, Pain drug therapy, Pain metabolism, Pain Measurement drug effects, Piperidines pharmacology, Pyrazoles pharmacology, Rats, Receptors, Opioid, mu agonists, Receptors, Opioid, mu antagonists & inhibitors, Somatostatin analogs & derivatives, Somatostatin pharmacology, Fear drug effects, N-Methylaspartate pharmacology, Nociception drug effects, Periaqueductal Gray metabolism, Receptor, Cannabinoid, CB1 metabolism, Receptors, Opioid, mu metabolism
- Abstract
Evidence indicates that periaqueductal gray matter (PAG) plays an important role in defensive responses and pain control. The activation of cannabinoid type-1 (CB1) or mu-opioid (MOR) receptors in the dorsal region of this structure (dPAG) inhibits fear and facilitates antinociception induced by different aversive stimuli. However, it is still unknown whether these two receptors work cooperatively in order to achieve these inhibitory actions. This study investigated the involvement and a likely interplay between CB1 and MOR receptors localized into the dPAG on the regulation of fear-like defensive responses and antinociception (evaluated in tail-flick test) evoked by dPAG chemical stimulation with N-methyl-d-aspartate (NMDA). Before the administration of NMDA, animals were first intra-dPAG injected with the CB1 agonist ACEA (0.5 pmol), or with the MOR agonist DAMGO (0.5 pmol) in combination with the respective antagonists AM251 (CB1 antagonist, 100 pmol) or CTOP (MOR antagonist, 1 nmol). To investigate the interplay between these receptors, microinjection of CTOP was combined with ACEA, or microinjection of AM251 was combined with DAMGO. Our results showed that both the intra-PAG treatments with ACEA or DAMGO inhibited NMDA-induced freezing expression, whereas only the treatment with DAMGO increased antinociception induced with NMDA, which are completely blocked by its respective antagonists. Interestingly, the inhibitory effects of ACEA or DAMGO on freezing was blocked by CTOP and AM251, respectively, indicating a functional interaction between these two receptors in the mediation of defensive behaviors. However, this cooperative interaction was not observed during the NMDA-induced antinociception. Our findings indicate that there is a cooperative action between the MOR and CB1 receptors within the dPAG and it is involved in the mediation of NMDA-induced defensive responses. Additionally, the MORs into the dPAG are involved in the modulation of the antinociceptive effects that follow a fear-like defense-reaction induced by dPAG chemical stimulation with NMDA., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes.
- Author
-
Chaves YC, Genaro K, Stern CA, de Oliveira Guaita G, de Souza Crippa JA, da Cunha JM, and Zanoveli JM
- Subjects
- Animals, Diabetes Mellitus, Experimental physiopathology, Disease Models, Animal, Male, Norepinephrine pharmacology, Rats, Wistar, Serotonin pharmacology, Behavior, Animal drug effects, Cannabidiol pharmacology, Diabetes Mellitus, Experimental drug therapy, Hippocampus drug effects
- Abstract
The prevalence rates of depression and anxiety are at least two times higher in diabetic patients, increasing morbidity and mortality. Cannabidiol (CBD) has been identified as a therapeutic agent viable to treat diverse psychiatric disorders. Thus, this study aimed to investigate the effect of CBD treatment (once a day for 14 days starting two weeks after diabetes induction; at doses of 0, 3, 10 or 30 mg/kg, i.p.) on depression- and anxiety-like behaviors associated with experimental diabetes induced by streptozotocin (60 mg/kg; i.p.) in rats. Levels of plasma insulin, blood glucose, and weight gain were evaluated in all experimental groups, including a positive control group treated with imipramine. The rats were tested in the modified forced swimming test (mFST) and elevated plus maze (EPM) test. Besides, the levels of serotonin (5-HT), noradrenaline (NA) and dopamine (DA) in two emotion-related brain regions, the prefrontal cortex (PFC) and hippocampus (HIP) were evaluated using high-pressure liquid chromatography. Our results showed that CBD treatment (only at the higher dose of 30 mg/kg) reduced the exaggerated depressive- and anxiogenic-like behaviors of diabetic (DBT) rats, which may be associated with altered 5-HT, NA and/or DA levels observed in the PFC and HIP. Treatment with CBD (higher dose) also induced a significant increase in weight gain and the insulin levels (and consequently reduced glycemia) in DBT rats. The long-term CBD effects gave rise to novel therapeutic strategies to limit the physiological and neurobehavioral deficits in DBT rats. This approach provided evidence that CBD can be useful for treating psychiatry comorbidities in diabetic patients., Competing Interests: Declaration of Competing Interest JAC is co-inventor (Mechoulam R, JC, Guimaraes FS, AZ, JH, Breuer A) of the patent “Fluorinated CBD compounds, compositions and uses thereof. Pub. No.: WO/2014/108899. International Application No.: PCT/IL2014/050023” Def. US no. Reg. 62193296; 29/07/2015; INPI on 19/08/2015 (BR1120150164927). The University of São Paulo has licensed the patent to Phytecs Pharm (USP Resolution No. 15.1.130002.1.1). The University of São Paulo has an agreement with Prati-Donaduzzi (Toledo, Brazil) to “develop a pharmaceutical product containing synthetic cannabidiol and prove its safety and therapeutic efficacy in the treatment of epilepsy, schizophrenia, Parkinson’s disease, and anxiety disorders.” JAC has received travel support from and was medical advisor of SCBD Centre. JAC has received a grant from University Global Partnership Network (UGPN) – “Global priorities in cannabinoid research excellence.’’ JAC is member of the international advisory board of The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), funded by the National Health and Medical Research Council through the Centre of Research Excellence)., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
26. Antinociceptive and Anti-Inflammatory Effects of Bixin, a Carotenoid Extracted from the Seeds of Bixa orellana.
- Author
-
Pacheco SDG, Gasparin AT, Jesus CHA, Sotomaior BB, Ventura ACSSB, Redivo DDB, Cabrini DA, Gaspari Dias JF, Miguel MD, Miguel OG, and da Cunha JM
- Subjects
- Acetic Acid adverse effects, Analgesics chemistry, Animals, Anti-Inflammatory Agents chemistry, Carotenoids chemistry, Carrageenan adverse effects, Disease Models, Animal, Inflammation drug therapy, Male, Mice, Pain Measurement, Rats, Rats, Wistar, Analgesics pharmacology, Anti-Inflammatory Agents pharmacology, Bixaceae chemistry, Carotenoids pharmacology, Edema drug therapy
- Abstract
Bixin is the main natural apocarotenoid extracted from the seeds of Bixa orellana, widely used as a cosmetic and textile colorant. Despite the description of several pharmacological properties of B. orellana extracts, little has been studied regarding the pharmacological properties of bixin. Then we aimed to investigate the potential anti-inflammatory and antinociceptive effect of bixin in preclinical models of inflammation and acute pain. The anti-inflammatory activity of bixin (15 or 30 mg/kg, orally) was determined using carrageenan-induced paw edema and the myeloperoxidase (MPO) activity in male Wistar rats. The antinociceptive effect of bixin was assessed in the formalin and hot plate tests in rats (at same doses) and in the acetic acid-induced writhing test in Swiss albino male mice (at doses of 27 or 53 mg/kg). General locomotor activity was evaluated in the open field test. Only the higher dose of bixin significantly decreased the carrageenan-induced paw edema and the MPO activity and increased the latency time in the hot plate. Both doses of bixin significantly reduced the number of flinches in both phases of the formalin test and the number of acetic acid-induced writhings without changing the locomotor performance in the open field test. This study validates the use of bixin as an anti-inflammatory trough mechanism related to the reduction of neutrophil migration. Furthermore, this is the first report showing the antinociceptive property of bixin, which does not appear to be related to the sedative effect. Further studies are necessary to characterize the mechanisms involved in these effects., Competing Interests: The authors declare that they have no conflict of interest., (Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2019
- Full Text
- View/download PDF
27. Acute antinociceptive effect of fish oil or its major compounds, eicosapentaenoic and docosahexaenoic acids on diabetic neuropathic pain depends on opioid system activation.
- Author
-
Redivo DDB, Jesus CHA, Sotomaior BB, Gasparin AT, and Cunha JM
- Subjects
- Analgesics pharmacology, Analgesics, Opioid therapeutic use, Animals, Diabetes Mellitus metabolism, Fatty Acids metabolism, Fatty Acids, Omega-3 administration & dosage, Fatty Acids, Omega-3 metabolism, Fish Oils administration & dosage, Fish Oils pharmacology, Hyperalgesia drug therapy, Male, Narcotic Antagonists therapeutic use, Neuralgia drug therapy, Rats, Rats, Wistar, Receptors, Opioid, mu drug effects, Receptors, Opioid, mu metabolism, Diabetic Neuropathies drug therapy, Docosahexaenoic Acids pharmacology, Eicosapentaenoic Acid pharmacology
- Abstract
Diabetic neuropathic pain is one of the most common and debilitating complications of diabetes whose available treatments are poorly effective. Currently, omega-3 polyunsaturated fatty acids (ω-3 PUFAs) have been widely studied as a treatment of many types of pain, including inflammatory, spontaneous and neuropathic pain. However, little is known about the potential antinociceptive effect of ω-3 PUFAs (fish oil; FO or its major fatty acids, eicosapentaenoic -EPA and docosahexaenoic acids-DHA), in diabetic neuropathic pain as well as the mechanisms involved. To test, streptozotocin (STZ) -induced diabetic male Wistar rats were submitted to acute treatment with FO, EPA or DHA at the second and fourth weeks after diabetes induction (at the beginning and peak of development of mechanical allodynia, respectively). The cumulative effect of these compounds after a sub-chronic treatment for two weeks was also evaluated as well as the role of central μ-opioid receptors. It was observed that acute oral treatment with FO (0.5, 1 or 3 g/kg), EPA or DHA (100, 200 or 400 mg/kg) at the 2
nd or at the 4th week after STZ significantly reverted the mechanical allodynia of diabetic animals, without altering the hyperglycemia or reduced weight gain. Moreover, the sub-chronic treatment with FO, EPA or DHA induced a sustained antinociceptive effect in diabetic animals. Intriguingly, the intrathecal treatment with a μ-opioid receptor antagonist (CTOP; 10 μg/rat) completely prevented the acute effect of FO, EPA or DHA. Taken together, our data suggest that ω-3 PUFAs may represent a promising therapeutic outcome for diabetic neuropathic pain, probably acting through the opioid system activation., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
28. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors.
- Author
-
Jesus CHA, Redivo DDB, Gasparin AT, Sotomaior BB, de Carvalho MC, Genaro K, Zuardi AW, Hallak JEC, Crippa JA, Zanoveli JM, and da Cunha JM
- Subjects
- Animals, Cannabidiol metabolism, Diabetes Mellitus, Experimental drug therapy, Disease Models, Animal, Hyperalgesia metabolism, Male, Neuralgia drug therapy, Piperazines pharmacology, Piperidines pharmacology, Pyrazoles pharmacology, Pyridines pharmacology, Rats, Rats, Wistar, Receptor, Serotonin, 5-HT1A metabolism, Streptozocin pharmacology, Cannabidiol pharmacology, Hyperalgesia drug therapy, Receptor, Serotonin, 5-HT1A drug effects
- Abstract
Most diabetic patients describe moderate to severe pain symptoms whose pharmacological treatment is palliative and poorly effective. Cannabidiol (CBD) has shown promising results in painful conditions. Then, we aimed to investigate the potential antinociceptive effect of CBD over the mechanical allodynia in streptozotocin-induced diabetic (DBT) rats, as well as its involved mechanisms. Wistar adult male diabetic rats were treated acutely or sub-chronically (for 14 days) with CBD (0.1, 0.3 or 3 mg/kg, intraperitoneal; i.p.) and had their mechanical threshold assessed using the electronic Von Frey. Acute treatment with CBD (at doses of 0.3 and 3 mg/kg) exerted a significant anti-allodynic effect, which is not associated with locomotor impairment. The antinociceptive effect of CBD (3 mg/kg) was not altered by the pre-treatment with CB
1 or CB2 receptor antagonists (AM251 and AM630; respectively; both at a dose of 1 mg/kg, i.p.) nor by glycine receptor antagonist (strychnine hydrochloride, 10 μg/rat, intrathecal, i.t.). However, this effect was completely prevented by the pre-treatment with the selective 5-HT1A receptor antagonist WAY 100135 (3 μg/rat, i.t.). Sub-chronic treatment with CBD (0.3 or 3 mg/kg) induced a sustained attenuation of the mechanical allodynia in DBT rats. DBT rats presented significantly lower spinal cord levels of serotonin, which was prevented by the daily treatment with CBD (0.3 mg/kg). Taken together, our data suggest that CBD may be effective in the treatment of painful diabetic neuropathy and this effect seems to be potentially mediated by the serotonergic system activation through 5-HT1A receptors., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
29. Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in rats.
- Author
-
Gerbatin RR, Silva LFA, Hoffmann MS, Della-Pace ID, do Nascimento PS, Kegler A, de Zorzi VN, Cunha JM, Botelho P, Neto JBT, Furian AF, Oliveira MS, Fighera MR, and Royes LFF
- Subjects
- Animals, Brain Injuries, Traumatic drug therapy, Brain Injuries, Traumatic pathology, Brain Waves drug effects, CA3 Region, Hippocampal metabolism, CA3 Region, Hippocampal pathology, Cell Death drug effects, Creatine therapeutic use, Epilepsy, Post-Traumatic drug therapy, Flunitrazepam metabolism, Glutamate Decarboxylase metabolism, Male, Neuroprotective Agents therapeutic use, Pentylenetetrazole, Radioligand Assay, Rats, Seizures chemically induced, Time Factors, Tritium metabolism, Brain Injuries, Traumatic complications, Creatine pharmacology, Epilepsy, Post-Traumatic complications, Epilepsy, Post-Traumatic prevention & control, GABAergic Neurons drug effects, Seizures complications, Seizures prevention & control
- Abstract
Traumatic brain injury (TBI) is a devastating disease frequently followed by behavioral disabilities including post-traumatic epilepsy (PTE). Although reasonable progress in understanding its pathophysiology has been made, treatment of PTE is still limited. Several studies have shown the neuroprotective effect of creatine in different models of brain pathology, but its effects on PTE is not elucidated. Thus, we decided to investigate the impact of delayed and chronic creatine supplementation on susceptibility to epileptic seizures evoked by pentylenetetrazol (PTZ) after TBI. Our experimental data revealed that 4 weeks of creatine supplementation (300 mg/kg, p.o.) initiated 1 week after fluid percussion injury (FPI) notably increased the latency to first myoclonic and tonic-clonic seizures, decreased the time spent in tonic-clonic seizure, seizure intensity, epileptiform discharges and spindle oscillations induced by a sub-convulsant dose of PTZ (35 mg/kg, i.p.). Interestingly, this protective effect persists for 1 week even when creatine supplementation is discontinued. The anticonvulsant effect of creatine was associated with its ability to reduce cell loss including the number of parvalbumin positive (PARV+) cells in CA3 region of the hippocampus. Furthermore, creatine supplementation also protected against the reduction of GAD67 levels, GAD activity and specific [
3 H]flunitrazepam binding in the hippocampus. These findings showed that chronic creatine supplementation may play a neuroprotective role on brain excitability by controlling the GABAergic function after TBI, providing a possible new strategy for the treatment of PTE., (Copyright © 2019. Published by Elsevier Inc.)- Published
- 2019
- Full Text
- View/download PDF
30. Abnormal Eye and Cranial Movements Triggered by Examination in People with Functional Neurological Disorder.
- Author
-
Teodoro T, Cunha JM, Abreu LF, Yogarajah M, and Edwards MJ
- Abstract
The diagnosis of functional neurological disorder (FND) relies on the demonstration of positive symptoms and signs, as supported by recent changes in DSM5. We recorded the findings of routine clinical eye movement assessment in 101 consecutive new patients with FND. Clinical examination triggered facial and eye movement disorders in 46% of patients, all with positive characteristics of functional movement disorder. These are useful as supporting features in making a positive diagnosis of FND.
- Published
- 2018
- Full Text
- View/download PDF
31. Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats.
- Author
-
de Morais H, Chaves YC, Waltrick APF, Jesus CHA, Genaro K, Crippa JA, da Cunha JM, and Zanoveli JM
- Subjects
- Animals, Depression blood, Depression psychology, Diabetes Mellitus, Experimental blood, Diabetes Mellitus, Experimental psychology, Dose-Response Relationship, Drug, Male, Rats, Rats, Wistar, Swimming psychology, Antidepressive Agents administration & dosage, Benzamides administration & dosage, Cannabidiol administration & dosage, Carbamates administration & dosage, Depression drug therapy, Diabetes Mellitus, Experimental drug therapy
- Abstract
Depression associated with diabetes has been described as a highly debilitating comorbidity. Due to its complex and multifactorial mechanisms, the treatment of depression associated with diabetes represents a clinical challenge. Cannabidiol (CBD), the non-psychotomimetic compound derived from Cannabis sativa, has been pointed out as a promising compound for the treatment of several psychiatric disorders. Here, we evaluated the potential antidepressant-like effect of acute or sub-chronic treatment with CBD in diabetic rats using the modified forced swimming test (mFST). Also, to better understand the functionality of the endocannabinoid system in diabetic animals we also evaluated the effect of URB597, a fatty acid amide hydrolase inhibitor. Four weeks after the treatment with streptozotocin (60 mg/kg; i.p.; diabetic group-DBT) or citrate buffer (i.p.; normoglycemic group-NGL), DBT animals received an acute intraperitoneal injection of CBD (0, 0.3, 3, 10, 30 or 60 mg/kg), 1 h before the mFST, or URB597 (0, 0.1, 0.3 or 1 mg/kg) 2 h before the mFST. In another set of experiments, animals were sub-chronically treated with CBD (0, 0.3, 3, 30 or 60 mg/kg i.p.), 24, 5 and 1 h before the mFST or URB597 (0, 0.1, 0.3 or 1 mg/kg i.p.) 24, 5 and 2 h before the mFST. The NGL group was acutely treated with CBD (0, 30 mg/kg i.p.) or URB597 (0, 0.3 mg/kg; i.p.). Acute treatment with either CBD or URB induced an antidepressant-like effect in NGL rats, but not in DBT rats. However, sub-chronic treatment with CBD (only at a dose of 30 mg/kg), but not with URB597, induced a mild antidepressant-like effect in DBT animals. Neither body weight nor blood glucose levels were altered by treatments. Considering the importance of the endocannabinoid system to the mechanism of action of many antidepressant drugs, the mild antidepressant-like effect of the sub-chronic treatment with CBD, but not with URB597 does not invalidate the importance of deepening the studies involving the endocannabinoid system particularly in DBT animals., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
32. Dactylogyrids (Platyhelminthes, Monogenoidea) from the gills of Hoplias malabaricus (Characiformes: Erythrinidae) from coastal rivers of the Oriental Amazon Basin: species of Urocleidoides and Constrictoanchoratus n. gen.
- Author
-
Ferreira KDC, Rodrigues ARO, Cunha JM, and Domingues MV
- Subjects
- Animals, Brazil epidemiology, Fish Diseases epidemiology, Host Specificity, Host-Parasite Interactions, Platyhelminths anatomy & histology, Platyhelminths genetics, Characiformes parasitology, Fish Diseases parasitology, Gills parasitology, Platyhelminths classification, Platyhelminths isolation & purification, Rivers parasitology
- Abstract
Five species of Urocleidoides (one new) and two new species of Constrictoanchoratus n. gen. are described in this study. All were collected from the gills of Hoplias malabaricus (Characiformes: Erythrinidae) captured in six localities of coastal rivers of the north-eastern sector the State of Pará (Oriental Amazon): Urocleidoides brasiliensis Rosim, Mendoza-Franco & Luque, 2011; Urocleidoides bulbophallus n. sp.; Urocleidoides cuiabai Rosim, Mendoza-Franco & Luque, 2011; Urocleidoides eremitus Kritsky, Thatcher & Boeger, 1986; Urocleidoides malabaricusi Rosim, Mendoza-Franco & Luque, 2011; Constrictoanchoratus lemmyi n. gen. n. sp.; and Constrictoanchoratus ptilonophallus n. gen. n. sp. This is the first reported occurrence of the four previously described species of Urocleidoides parasitizing H. malabaricus from streams in the Oriental Amazon Basin. The analysis of voucher specimens of U. eremitus parasitizing the gills of H. malabaricus from the Upper Paraná River floodplain in the limits of States of Paraná and Mato Grosso do Sul, Brazil, indicates that these specimens are members of a new species of Urocleidoides, described here as Urocleidoides paranae n. sp. Constrictoanchoratus n. gen. is proposed for the species with a male copulatory organ sclerotized, coiled, clockwise; ventral anchor with elongate superficial root, inconspicuous deep root; dorsal anchor with inconspicuous roots, and a constriction at the intersection between the shaft and the point. The host-parasite diversity scenario and host specificity of the species of Constrictoanchoratus n. gen. and Urocleidoides from the gills of H. malabaricus are also discussed in this study.
- Published
- 2018
- Full Text
- View/download PDF
33. Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva.
- Author
-
Cunha JM, Abbehusen M, Suarez M, Valenzuela J, Teixeira CR, and Brodskyn CI
- Subjects
- Animals, Female, Mice, Phlebotomus chemistry, Protozoan Vaccines administration & dosage, Protozoan Vaccines immunology, Recombinant Proteins administration & dosage, Saliva chemistry, Salivary Proteins and Peptides administration & dosage, Leishmania braziliensis immunology, Leishmaniasis prevention & control, Phlebotomus immunology, Psychodidae parasitology, Recombinant Proteins immunology, Salivary Proteins and Peptides immunology, Vaccination methods
- Abstract
Leishmania is transmitted in the presence of sand fly saliva. Protective immunity generated by saliva has encouraged identification of a vector salivary-based vaccine. Previous studies have shown that immunization with LJM11, a salivary protein from Lutzomyia longipalpis, is able to induce a Th1 immune response and protect mice against bites of Leishmania major-infected Lutzomyia longipalpis. Here, we further investigate if immunization with LJM11 recombinant protein is able to confer cross-protection against infection with Leishmania braziliensis associated with salivary gland sonicate (SGS) from Lutzomyia intermedia or Lu. longipalpis. Mice immunized with LJM11 protein exhibited an increased production of anti-LJM11 IgG, IgG1 and IgG2a and a DTH response characterized by an inflammatory infiltrate with the presence of CD4
+ IFN-γ+ T cells. LJM11-immunized mice were intradermally infected in the ear with L. braziliensis in the presence of Lu. longipalpis or Lu. intermedia SGS. A significant reduction of parasite numbers in the ear and lymph node in the group challenged with L. braziliensis plus Lu. longipalpis SGS was observed, but not when the challenge was performed with L. braziliensis plus Lu. intermedia SGS. A higher specific production of IFN-γ and absence of IL-10 by lymph node cells were only observed in LJM11 immunized mice after infection. After two weeks, a similar frequency of CD4+ IFN-γ+ T cells was detected in LJM11 and BSA groups challenged with L. braziliensis plus Lu. longipalpis SGS, suggesting that early events possibly triggered by immunization are essential for protection against Leishmania infection. Our findings support the specificity of saliva-mediated immune responses and reinforce the importance of identifying cross-protective salivary antigens., (Copyright © 2017 Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
34. A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats.
- Author
-
Gambeta E, Sestile CC, Fogaça MV, Guimarães FS, Audi EA, da Cunha JM, Zangrossi H Jr, Shimene de Melo Yamashita P, and Zanoveli JM
- Subjects
- Animals, Anxiety metabolism, Diabetes Mellitus, Experimental psychology, Disease Models, Animal, Escape Reaction drug effects, Male, Rats, Rats, Wistar, Receptor, Serotonin, 5-HT1A metabolism, Receptor, Serotonin, 5-HT2A metabolism, Serotonin metabolism, Serotonin 5-HT1 Receptor Agonists pharmacology, Panic physiology, Periaqueductal Gray physiopathology, Serotonergic Neurons metabolism
- Abstract
It is known that diabetic (DBT) animals present dysregulation on the serotonergic system in several brain areas associated with anxiety-like responses. The aim of this study was to investigate the involvement of 5-HT1A receptors on dorsal periaqueductal gray (dPAG) in the behavioral response related to panic disorder in type-1 DBT animals. For this, the escape response by electric stimulation (ES) of dPAG in DBT and normoglycemic (NGL) animals was assessed. Both NGL and DBT animals were exposed to an open-field test (OFT) 28 days after DBT confirmation. The current threshold to induce escape behavior in DBT animals was reduced compared with NGL animals. No impairment in locomotor activity was observed when DBT animals were compared with NGL animals. An intra-dPAG injection of the 5-HT1A receptor agonist (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) increased the [INCREMENT] threshold in both DBT and NGL, suggesting a panicolytic-like effect. DBT animals presented a more pronounced panicolytic-like response compared with NGL as a higher [INCREMENT] threshold was observed after 8-OH-DPAT treatment, which could be a consequence of the increased expression of the 5-HT1A receptor in the dPAG from DBT animals. Our results are in line with the proposal that a deficiency in serotonergic modulation of the dPAG is involved in triggering the panic attack and the 5-HT1A receptors might be essential for the panicolytic-like response.
- Published
- 2017
- Full Text
- View/download PDF
35. History of Seborrheic Dermatitis: Conceptual and Clinico-Pathologic Evolution.
- Author
-
Mameri ACA, Carneiro S, Mameri LMA, Telles da Cunha JM, and Ramos-E-Silva M
- Subjects
- Dermatitis, Seborrheic diagnosis, Dermatitis, Seborrheic etiology, Dermatitis, Seborrheic pathology, Eczema diagnosis, History, 19th Century, History, 20th Century, History, 21st Century, Humans, Terminology as Topic, Dermatitis, Seborrheic history
- Abstract
Seborrheic dermatitis is an inflammatory and chronic disease with a high incidence and prevalence (1% to 3% in the general population, 3% to 5% in young adults, and 40% to 80% in HIV-positive individuals). Although the condition was first described in 1887, its clinical aspects and clinical forms have still not been well individualized, nor has its etiopathogenesis been fully elucidated. The disease, despite having clinical features similar to dermatitis, does not have the same histopathologic features or the same progressive clinical behavior. This contribution reviews the history of seborrheic dermatitis.
- Published
- 2017
36. Fish oil prevents rodent anxious states comorbid with diabetes: A putative involvement of nitric oxide modulation.
- Author
-
Siba IP, Bortolanza M, Frazão Vital MAB, Andreatini R, da Cunha JM, Del Bel EA, and Zanoveli JM
- Subjects
- Animals, Arginine pharmacology, Disease Models, Animal, Enzyme Inhibitors pharmacology, Fish Oils administration & dosage, Indazoles pharmacology, Male, Nitric Oxide Synthase Type I antagonists & inhibitors, Rats, Rats, Wistar, Streptozocin pharmacology, Amygdala metabolism, Anxiety metabolism, Anxiety prevention & control, Diabetes Mellitus, Experimental metabolism, Fish Oils pharmacology, Hippocampus metabolism, Nitric Oxide metabolism, Nitric Oxide Synthase Type I metabolism, Periaqueductal Gray metabolism
- Abstract
There is an urgent need to understand the pathophysiological mechanisms related to anxiety associated with diabetes, seeking more effective alternative treatments to treat it. For that, the effect of a preventive and prolonged treatment with fish oil (FO), a source of omega-3 polyunsaturated fatty acid, was tested in streptozotocin-diabetic (DBT) rats submitted to the anxiety tests. Additionally, an immunohistochemistry for neuronal NO synthase (nNOS) was performed in brain areas related to anxiety, such as lateral amygdala (AMY), hippocampus (HIP) and dorsolateral periaqueductal gray (dlPAG). Lastly, the effect of NO precursor L-arginine (L-Arg) or nNOS inhibitor 7-nitroindazole (7-NI) was tested in DBT animals treated with vehicle (VEH) or FO. Our data demonstrated that vehicle-treated DBT animals exhibited a more pronounced anxiogenic-like response and also presented high nNOS levels in the AMY, HIP and rostral dlPAG, what were both significantly prevented by FO treatment. This treatment was able to prevent the impairment in locomotor activity besides improving the high glycemic levels in DBT rats. Interestingly, while injection of 7-NI or L-Arg in VEH-treated DBT animals induced an anxiogenic-like and anxiolytic-like effect, respectively; the previous treatment with both L-Arg and 7-NI in FO-DBT animals abolished the anxiolytic-like effect induced by FO treatment. Altogether, our data support the hypothesis that a dysregulation in the NO production in brain areas as AMY, HIP and dlPAG may contribute to the mechanisms that link anxiety and diabetes, and the prevention of nNOS brain expression changes induced by a prolonged treatment with FO may be an important mechanism related to its anxiolytic-like effect., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
37. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
- Author
-
da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC, Rizzo de Souza LE, Zanata SM, Brandão ML, Cunha TM, Ferraz AC, Cunha JM, and Zanoveli JM
- Subjects
- Animals, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Behavior, Animal, Blood Glucose metabolism, Cytokines metabolism, Depression blood, Depression pathology, Depression physiopathology, Diabetes Mellitus, Experimental blood, Enzyme Inhibitors pharmacology, Enzyme Inhibitors therapeutic use, Fluoxetine pharmacology, Fluoxetine therapeutic use, Hippocampus metabolism, Hippocampus pathology, Ibuprofen pharmacology, Ibuprofen therapeutic use, Indoleamine-Pyrrole 2,3,-Dioxygenase metabolism, Inflammation Mediators metabolism, Male, Minocycline pharmacology, Minocycline therapeutic use, Motor Activity drug effects, Norepinephrine metabolism, Rats, Wistar, Serotonin metabolism, Swimming, Tryptophan analogs & derivatives, Tryptophan pharmacology, Tryptophan therapeutic use, Weight Gain drug effects, Depression drug therapy, Diabetes Mellitus, Experimental psychology, Indoleamine-Pyrrole 2,3,-Dioxygenase antagonists & inhibitors, Kynurenine metabolism, Molecular Targeted Therapy
- Abstract
Diabetes is a chronic disease associated with depression whose pathophysiological mechanisms that associate these conditions are not fully elucidated. However, the activation of the indoleamine-2,3-dioxygenase (IDO), an enzyme that participate of the tryptophan metabolism leading to a decrease of serotonin (5-HT) levels and whose expression is associated with an immune system activation, has been proposed as a common mechanism that links depression and diabetes. To test this hypothesis, diabetic (DBT) and normoglycemic (NGL) groups had the cytokines (TNFα, IL-1β, and IL-6) and 5-HT and norepinephrine (NE) levels in the hippocampus (HIP) evaluated. Moreover, the effect of the selective serotonin reuptake inhibitor fluoxetine (FLX), IDO direct inhibitor 1-methyl-tryptophan (1-MT), anti-inflammatory and IDO indirect inhibitor minocycline (MINO), or non-selective cyclooxygenase inhibitor ibuprofen (IBU) was evaluated in DBT rats submitted to the modified forced swimming test (MFST). After the behavioral test, the HIP was obtained for IDO expression by Western blotting analysis. DBT rats exhibited a significant increase in HIP levels of TNFα, IL-1β, and IL-6 and a decrease in HIP 5-HT and NA levels. They also presented a depressive-like behavior which was reverted by all employed treatments. Interestingly, treatment with MINO, IBU, or FLX but not with 1-MT reduced the increased IDO expression in the HIP from DBT animals. Taken together, our data support our hypothesis that neuroinflammation in the HIP followed by IDO activation with a consequent decrease in the 5-HT levels can be a possible pathophysiological mechanism that links depression to diabetes.
- Published
- 2016
- Full Text
- View/download PDF
38. Time-varying associations of suicide with deployments, mental health conditions, and stressful life events among current and former US military personnel: a retrospective multivariate analysis.
- Author
-
Shen YC, Cunha JM, and Williams TV
- Subjects
- Humans, Military Personnel statistics & numerical data, Multivariate Analysis, Retrospective Studies, Risk Factors, Time Factors, United States, Life Change Events, Mental Disorders psychology, Military Personnel psychology, Suicide statistics & numerical data
- Abstract
Background: US military suicides have increased substantially over the past decade and currently account for almost 20% of all military deaths. We investigated the associations of a comprehensive set of time-varying risk factors with suicides among current and former military service members., Methods: We did a retrospective multivariate analysis of all US military personnel between 2001 and 2011 (n=110 035 573 person-quarter-years, representing 3 795 823 service members). Outcome was death by suicide, either during service or post-separation. We used Cox proportional hazard models at the person-quarter level to examine associations of deployment, mental disorders, history of unlawful activity, stressful life events, and other demographic and service factors with death by suicide., Findings: The strongest predictors of death by suicide were current and past diagnoses of self-inflicted injuries, major depression, bipolar disorder, substance use disorder, and other mental health conditions (compared with service members with no history of diagnoses, the hazard ratio [HR] ranged from 1·4 [95% CI 1·14-1·72] to 8·34 [6·71-10·37]). Compared with service members who were never deployed, hazard rates of suicide (which represent the probability of death by suicide in a specific quarter given that the individual was alive in the previous quarter) were lower among the currently deployed (HR 0·50, 95% CI 0·40-0·61) but significantly higher in the quarters following first deployment (HR 1·51 [1·17-1·96] if deployed in the previous three quarters; 1·14 [1·06-1·23] if deployed four or more quarters ago). The hazard rate of suicide increased within the first year of separation from the military (HR 2·49, 95% CI 2·12-2·91), and remained high for those who had separated from the military 6 or more years ago (HR 1·63, 1·45-1·82)., Interpretation: The increased hazard rate of death by suicide for military personnel varies by time since exposure to deployment, mental health diagnoses, and other stressful life events. Continued monitoring is especially needed for these high-risk individuals. Additional information should be gathered to address the persistently raised risk of suicide among service members after separation., Funding: Partly funded by the Naval Research Program., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
39. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors.
- Author
-
de Morais H, de Souza CP, da Silva LM, Ferreira DM, Baggio CH, Vanvossen AC, Cristina de Carvalho M, da Silva-Santos JE, Bertoglio LJ, Cunha JM, and Zanoveli JM
- Subjects
- Animals, Indoles pharmacology, Male, Norepinephrine metabolism, Piperidines pharmacology, Pyrazoles pharmacology, Rats, Rats, Wistar, Receptor, Cannabinoid, CB1 biosynthesis, Serotonin metabolism, Swimming psychology, Arachidonic Acids therapeutic use, Behavior, Animal drug effects, Brain Chemistry drug effects, Calcium Channel Blockers therapeutic use, Depression drug therapy, Depression etiology, Diabetes Mellitus, Experimental psychology, Endocannabinoids therapeutic use, Oxidative Stress drug effects, Polyunsaturated Alkamides therapeutic use, Receptor, Cannabinoid, CB1 drug effects
- Abstract
The pathophysiology associated with increased prevalence of depression in diabetics is not completely understood, although studies have pointed the endocannabinoid system as a possible target. Then, we aimed to investigate the role of this system in the pathophysiology of depression associated with diabetes. For this, diabetic (DBT) male Wistar rats were intraperitoneally treated with cannabinoid CB1 (AM251, 1mg/kg) or CB2 (AM630, 1mg/kg) receptor antagonists followed by anandamide (AEA, 0.005mg/kg) and then submitted to the forced swimming test (FST). Oxidative stress parameters, CB1 receptor expression and serotonin (5-HT) and noradrenaline levels in the hippocampus (HIP) and prefrontal cortex (PFC) were also performed. It was observed that DBT animals presented a more pronounced depressive-like behavior and increase of CB1 receptor expression in the HIP. AEA treatment induced a significant improvement in the depressive-like behavior, which was reversed by the CB1 antagonist AM251, without affecting the hyperglycemia or weight gain. AEA was also able to restore the elevated CB1 expression and also to elevate the reduced level of 5-HT in the HIP from DBT animals. In addition, AEA restored the elevated noradrenaline levels in the PFC and induced a neuroprotective effect by restoring the decreased reduced glutathione and increased lipid hydroperoxides levels along with the decreased superoxide dismutase activity observed in HIP or PFC. Together, our data suggest that in depression associated with diabetes, the endocannabinoid anandamide has a potential to induce neuroadaptative changes able to improve the depressive-like response by its action as a CB1 receptor agonist., (Copyright © 2016 Elsevier B.V. and ECNP. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
40. Decision making and senior management: the implementation of change projects covering clinical management in SUS hospitals.
- Author
-
Pacheco JM Júnior and Gomes R
- Subjects
- Brazil, Decision Making, Delivery of Health Care organization & administration, Hospitals, Public organization & administration
- Abstract
This paper analyses the decision making process for senior management in public hospitals that are a part of the National Health Service in Brazil (hereafter SUS) in relation to projects aimed at changing clinical management. The methodological design of this study is qualitative in nature taking a hermeneutics-dialectics perspective in terms of results. Hospital directors noted that clinical management projects changed the state of hospitals through: improving their organizations, mobilizing their staff in order to increase a sense of order and systemizing actions and available resources. Technical rationality was the principal basis used in the decision making process for managers. Due to the reality of many hospitals having fragmented organizations, this fact impeded the use of aspects related to rationality, such as economic and financial factors in the decision making process. The incremental model and general politics also play a role in this area. We concluded that the decision making process embraces a large array of factors including rational aspects such as the use of management techniques and the ability to analyze, interpret and summarize. It also incorporates subjective elements such as how to select values and dealing with people's working experiences. We recognized that management problems are wide in scope, ambiguous, complex and do not come with a lot of structure in practice.
- Published
- 2016
- Full Text
- View/download PDF
41. Effect of omega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes.
- Author
-
Redivo DD, Schreiber AK, Adami ER, Ribeiro DE, Joca SR, Zanoveli JM, and Cunha JM
- Subjects
- Animals, Brain-Derived Neurotrophic Factor metabolism, Cerebral Cortex metabolism, Depressive Disorder physiopathology, Diabetes Mellitus, Experimental physiopathology, Hippocampus metabolism, Hyperalgesia physiopathology, Male, Motor Activity, Rats, Wistar, Touch, Treatment Outcome, Depressive Disorder diet therapy, Diabetes Mellitus, Experimental diet therapy, Fatty Acids, Omega-3 administration & dosage, Fish Oils administration & dosage, Hyperalgesia diet therapy
- Abstract
Neuropathic pain and depression are very common comorbidities in diabetic patients. As the pathophysiological mechanisms are very complex and multifactorial, current treatments are only symptomatic and often worsen the glucose control. Thus, the search for more effective treatments are extremely urgent. In this way, we aimed to investigate the effect of chronic treatment with fish oil (FO), a source of omega-3 polyunsaturated fatty acid, over the mechanical allodynia and in depressive-like behaviors in streptozotocin-diabetic rats. It was observed that the diabetic (DBT) animals, when compared to normoglycemic (NGL) animals, developed a significant mechanical allodynia since the second week after diabetes induction, peaking at fourth week which is completely prevented by FO treatment (0.5, 1 or 3g/kg). Moreover, DBT animals showed an increase of immobility frequency and a decrease of swimming and climbing frequencies in modified forced swimming test (MFST) since the second week after diabetes injection, lasting up at the 4th week. FO treatment (only at a dose of 3g/kg) significantly decreased the immobility frequency and increased the swimming frequency, but did not induce significant changes in the climbing frequency in DBT rats. Moreover, it was observed that DBT animals had significantly lower levels of BDNF in both hippocampus and pre frontal cortex when compared to NGL rats, which is completely prevented by FO treatment. In conclusion, our study demonstrates that FO treatment was able to prevent the mechanical allodynia and the depressive-like behaviors in DBT rats, which seems to be related to its capacity of BDNF level restoration., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
42. Phytochemical and Antinociceptive, Anti-Inflammatory, and Antioxidant Studies of Smilax larvata (Smilacaceae).
- Author
-
Hirota BC, Paula CD, de Oliveira VB, da Cunha JM, Schreiber AK, Ocampos FM, Barison A, Miguel OG, and Miguel MD
- Abstract
The tea of aerial parts of Smilax larvata Griseb. (Smilacaceae) has been ethnopharmacologically used in Southern Brazil due to its anti-inflammatory action. In this study, ethanolic and organic extracts from aerial parts of S. larvata were phytochemically and pharmacologically characterized. The phytochemical analysis of EtOAc extract of S. larvata revealed the presence of three flavonoids, drabanemoroside, kaempferol 3- O - α -L-rhamnopyranosyl(1→2)- α -L-rhamnopyranoside, and kaempferol, the first two being isolated for the first time in this genus, two phenolic compounds p- hydroxybenzoic acid and p- coumaric acid, and alkaloids. In vitro assays demonstrated a potential antioxidant property of SLG. The treatment with SLG induced a significant reduction of the formalin-evoked flinches in rats, an effect reversed by opioid antagonist naloxone. Treatment with SLG also induced a significant increase in the hot plate latency and a decrease of intestinal motility by 45%. No effect was observed over nociceptive responses induced by a TRPA1 agonist mustard oil or over acetic acid-induced writhing in mice. Together, our data suggested that SLG has an in vivo antinociceptive effect, which seems to be associated with the opioid system activation. These findings support previous claims of medical use of Smilax larvata in the treatment of pain conditions., Competing Interests: The authors declare that they have no competing interests.
- Published
- 2016
- Full Text
- View/download PDF
43. Depression Associated with Diabetes: From Pathophysiology to Treatment.
- Author
-
Zanoveli JM, Morais Hd, Dias IC, Schreiber AK, Souza CP, and Cunha JM
- Subjects
- Comorbidity, Depression epidemiology, Diabetes Complications psychology, Diabetes Complications therapy, Diabetes Mellitus epidemiology, Diabetes Mellitus physiopathology, Humans, Hyperglycemia complications, Hyperglycemia physiopathology, Hyperglycemia psychology, Hypothalamo-Hypophyseal System physiopathology, Pituitary-Adrenal System physiopathology, Depression etiology, Depression therapy, Diabetes Mellitus psychology, Diabetes Mellitus therapy
- Abstract
Diabetes is a chronic and progressive syndrome commonly associated with several neuropsychiatric comorbities, of which depression is the most studied. The prevalence of depression is about two or three times higher in diabetic patients compared to the general population. It is believed that the diabetes - depression relation may be bidirectional, i.e., the depression can lead to diabetes and conversely diabetes could facilitate the emergence of depression. Depression is one of the most neglected symptoms in diabetic patients and is directly linked with lowering of quality of life. The treatment of depression in these patients is still quite ineffective and in many cases treatmentrefractory. Furthermore, some of the first choice drugs used to treat the depression affect the blood glucose control, aggravating the hyperglycemic state. These issues underscore the urgency in studies searching for new pharmacological targets for the treatment of depression associated with diabetes. For this, a better understanding of the pathophysiology that relates this comorbidity becomes critical. In this respect, this review will focus on some hypotheses that have been proposed to explain the mechanisms underlying depression associated with diabetes, highlighting the treatment options currently available and their limitations. Among these hypotheses, we will point out the hyperglycemia as a primary metabolic cause of the depression development, the involvement of the dysregulation of hypothalamic pituitary-adrenal (HPA) axis and of neurotransmitter systems, specially monoaminergic system. Besides, the role of oxidative stress, neuroinflammation and cell death, especially in hippocampus and prefrontal cortex, brain areas important for the mediation and modulation of emotional behavior will also be discussed. Finally, we will bring up the influence of the epigenetic regulation with respect to neuropsychiatric disorders.
- Published
- 2016
- Full Text
- View/download PDF
44. Surface modification of chitin using ultrasound-assisted and supercritical CO2 technologies for cobalt adsorption.
- Author
-
Dotto GL, Cunha JM, Calgaro CO, Tanabe EH, and Bertuol DA
- Subjects
- Adsorption, Animals, Chitin radiation effects, Chitin ultrastructure, Kinetics, Penaeidae, Ultrasonic Waves, Carbon Dioxide chemistry, Chitin chemistry, Cobalt chemistry
- Abstract
Ultrasound-assisted (UA) and supercritical CO2 technologies (SCO2) were used to modify the chitin surface and, improve its adsorption characteristics regarding to cobalt. Chitin, before and after the treatments, was characterized by N2 adsorption isotherms (BET), infrared spectroscopy (FT-IR), X-ray diffraction (XRD) and scanning electron microscopy (SEM). Unmodified and surface modified chitins were used as adsorbents to remove cobalt from aqueous solutions. The adsorption study was performed by equilibrium isotherms and kinetic curves. The chitin particle characteristics, such as, surface area, pore volume and porosity were improved by the UA and SCO2 treatments. The crystallinity index decreased after the UA and SCO2 treatments, and also, intense surface modifications were observed. Langmuir and Freundlich models were adequate to represent the adsorption equilibrium. The maximum adsorption capacities were 50.03, 83.94 and 63.08 mg g(-1) for unmodified chitin, UA surface modified chitin and SCO2 surface modified chitin. The adsorption kinetic curves were well represented by the pseudo-second order model. UA and SCO2 technologies are alternatives to modify the chitin surface and improve its adsorption characteristics., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
45. Diabetic neuropathic pain: Physiopathology and treatment.
- Author
-
Schreiber AK, Nones CF, Reis RC, Chichorro JG, and Cunha JM
- Abstract
Diabetic neuropathy is a common complication of both type 1 and type 2 diabetes, which affects over 90% of the diabetic patients. Although pain is one of the main symptoms of diabetic neuropathy, its pathophysiological mechanisms are not yet fully known. It is widely accepted that the toxic effects of hyperglycemia play an important role in the development of this complication, but several other hypotheses have been postulated. The management of diabetic neuropathic pain consists basically in excluding other causes of painful peripheral neuropathy, improving glycemic control as a prophylactic therapy and using medications to alleviate pain. First line drugs for pain relief include anticonvulsants, such as pregabalin and gabapentin and antidepressants, especially those that act to inhibit the reuptake of serotonin and noradrenaline. In addition, there is experimental and clinical evidence that opioids can be helpful in pain control, mainly if associated with first line drugs. Other agents, including for topical application, such as capsaicin cream and lidocaine patches, have also been proposed to be useful as adjuvants in the control of diabetic neuropathic pain, but the clinical evidence is insufficient to support their use. In conclusion, a better understanding of the mechanisms underlying diabetic neuropathic pain will contribute to the search of new therapies, but also to the improvement of the guidelines to optimize pain control with the drugs currently available.
- Published
- 2015
- Full Text
- View/download PDF
46. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
- Author
-
Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, Vermont C, Ahmad I, Shaw PJ, Telles da Cunha JM, Schlegel PG, Hough R, Fasth A, Kentouche K, Gruhn B, Fernandes JF, Lachance S, Bredius R, Resnick IB, Belohradsky BH, Gennery A, Fischer A, Gaspar HB, Schanz U, Seger R, Rentsch K, Veys P, Haddad E, Albert MH, and Hassan M
- Subjects
- Adolescent, Adult, Alemtuzumab, Antibodies, Monoclonal, Humanized administration & dosage, Antilymphocyte Serum administration & dosage, Busulfan administration & dosage, Child, Child, Preschool, Drug Therapy, Combination, Graft Survival drug effects, Graft vs Host Disease prevention & control, HLA Antigens, Humans, Immunosuppressive Agents administration & dosage, Infant, Prospective Studies, Transplantation Chimera physiology, Treatment Outcome, Vidarabine administration & dosage, Vidarabine analogs & derivatives, Young Adult, Granulomatous Disease, Chronic therapy, Hematopoietic Stem Cell Transplantation methods, Transplantation Conditioning methods
- Abstract
Background: In chronic granulomatous disease allogeneic haemopoietic stem-cell transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is complicated by graft-failure, graft-versus-host disease (GVHD), and transplant-related mortality. We examined the effect of a reduced-intensity conditioning regimen designed to enhance myeloid engraftment and reduce organ toxicity in these patients., Methods: This prospective study was done at 16 centres in ten countries worldwide. Patients aged 0-40 years with chronic granulomatous disease were assessed and enrolled at the discretion of individual centres. Reduced-intensity conditioning consisted of high-dose fludarabine (30 mg/m(2) [infants <9 kg 1·2 mg/kg]; one dose per day on days -8 to -3), serotherapy (anti-thymocyte globulin [10 mg/kg, one dose per day on days -4 to -1; or thymoglobuline 2·5 mg/kg, one dose per day on days -5 to -3]; or low-dose alemtuzumab [<1 mg/kg on days -8 to -6]), and low-dose (50-72% of myeloablative dose) or targeted busulfan administration (recommended cumulative area under the curve: 45-65 mg/L × h). Busulfan was administered mainly intravenously and exceptionally orally from days -5 to -3. Intravenous busulfan was dosed according to weight-based recommendations and was administered in most centres (ten) twice daily over 4 h. Unmanipulated bone marrow or peripheral blood stem cells from HLA-matched related-donors or HLA-9/10 or HLA-10/10 matched unrelated-donors were infused. The primary endpoints were overall survival and event-free survival (EFS), probabilities of overall survival and EFS at 2 years, incidence of acute and chronic GVHD, achievement of at least 90% myeloid donor chimerism, and incidence of graft failure after at least 6 months of follow-up., Findings: 56 patients (median age 12·7 years; IQR 6·8-17·3) with chronic granulomatous disease were enrolled from June 15, 2003, to Dec 15, 2012. 42 patients (75%) had high-risk features (ie, intractable infections and autoinflammation), 25 (45%) were adolescents and young adults (age 14-39 years). 21 HLA-matched related-donor and 35 HLA-matched unrelated-donor transplants were done. Median time to engraftment was 19 days (IQR 16-22) for neutrophils and 21 days (IQR 16-25) for platelets. At median follow-up of 21 months (IQR 13-35) overall survival was 93% (52 of 56) and EFS was 89% (50 of 56). The 2-year probability of overall survival was 96% (95% CI 86·46-99·09) and of EFS was 91% (79·78-96·17). Graft-failure occurred in 5% (three of 56) of patients. The cumulative incidence of acute GVHD of grade III-IV was 4% (two of 56) and of chronic graft-versus-host disease was 7% (four of 56). Stable (≥90%) myeloid donor chimerism was documented in 52 (93%) surviving patients., Interpretation: This reduced-intensity conditioning regimen is safe and efficacious in high-risk patients with chronic granulomatous disease., Funding: None., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
47. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats.
- Author
-
de Morais H, de Souza CP, da Silva LM, Ferreira DM, Werner MF, Andreatini R, da Cunha JM, and Zanoveli JM
- Subjects
- Animals, Catalase metabolism, Depression psychology, Diabetes Mellitus, Experimental psychology, Glutathione Reductase metabolism, Lipid Peroxidation physiology, Male, Rats, Rats, Wistar, Superoxide Dismutase metabolism, Behavior, Animal physiology, Depression metabolism, Diabetes Mellitus, Experimental metabolism, Hippocampus metabolism, Oxidative Stress physiology, Prefrontal Cortex metabolism
- Abstract
Depression is a common comorbid in diabetic patients. The pathophysiologic mechanisms that relate this comorbidity is not completely elucidated yet, although several lines of evidence point out that increased oxidative stress resulting from hyperglycemia may have a crucial role. Thus, the effect of prolonged treatment with insulin (INS), the antioxidant vitamin E (VIT E) or the antidepressant imipramine (IMI) was evaluated in animals submitted to forced swimming test. Oxidative stress parameters (lipid peroxidation product levels, reduced gluthatione levels and catalase and superoxide dismutase activities) were also evaluated in brain areas related to depression, prefrontal cortex (PFC) and hippocampus (HIP). Our data show that treatment of streptozotocin-induced diabetic (DBT) rats with INS (6 UI/day, s.c.) prevented the blood glucose increase, reduced the immobility time, an antidepressant-like behavior, and normalized the reduced weight gain. Although the VIT E treatment (300 mg/kg, p.o.) had not altered the blood glucose levels, this treatment was able to reduce the immobility time and to reestablish the reduced weight gain in DBT rats. Differently, treatment with IMI (15 mg/kg, i.p.) induced antidepressant-like behavior in normoglycemic besides DBT animals. While VIT E and IMI treatments restored only specific oxidative stress parameters, INS was able to prevent all changed parameters evaluated in both PFC and HIP from DBT animals. Therefore, our data provide further evidence of the importance of oxidative stress in PFC and HIP in the pathophysiology of depression related to diabetes., (Copyright © 2013. Published by Elsevier B.V.)
- Published
- 2014
- Full Text
- View/download PDF
48. Pluripotent stem cell transcription factors during human odontogenesis.
- Author
-
da Cunha JM, da Costa-Neves A, Kerkis I, and da Silva MC
- Subjects
- Ameloblasts cytology, Ameloblasts metabolism, Female, Fetus cytology, Humans, Male, Odontoblasts cytology, Odontoblasts metabolism, Pluripotent Stem Cells cytology, Tooth cytology, Cell Differentiation physiology, Fetus embryology, Gene Expression Regulation, Developmental physiology, Odontogenesis physiology, Pluripotent Stem Cells metabolism, Tooth embryology, Transcription Factors biosynthesis
- Abstract
Stem cells are capable of generating various cell lines and can be obtained from adult or embryonic tissues for clinical therapies. Stem cells from deciduous dental pulp are among those that are easily obtainable from adult tissues and have been widely studied because of their ability to differentiate into a variety of cell lines in the presence of various chemical mediators. We have analyze the expression of several proteins related to the differentiation and proliferative potential of cell populations that compose the tooth germ of human fetuses. We evaluate 20 human fetuses of both genders. After being paraffin-embedded, cap and bell stages of tooth germ development were subjected to immunohistochemistry for the following markers: Oct-4, Nanog, Stat-3 and Sox-2. The studied antibodies showed nuclear or cytoplasmic immunnostaining within various anatomical structures and with various degrees of expression, indicating the action of these proteins during tooth development. We conclude that the interrelationship between these transcription factors is complex and associated with self-renewal and cell differentiation. Our results suggest that the expression of Oct-4, Nanog, Sox-2 and Stat-3 are related to differentiation in ameloblasts and odontoblasts.
- Published
- 2013
- Full Text
- View/download PDF
49. Orofacial sensory changes after streptozotocin-induced diabetes in rats.
- Author
-
Nones CF, Reis RC, Jesus CH, Veronez DA, Cunha JM, and Chichorro JG
- Subjects
- Analgesics pharmacology, Analgesics therapeutic use, Animals, Diabetic Neuropathies drug therapy, Facial Pain drug therapy, Hyperalgesia drug therapy, Male, Morphine pharmacology, Morphine therapeutic use, Pain Measurement, Pain Threshold drug effects, Pain Threshold physiology, Physical Stimulation, Pregabalin, Rats, Rats, Wistar, gamma-Aminobutyric Acid analogs & derivatives, gamma-Aminobutyric Acid pharmacology, gamma-Aminobutyric Acid therapeutic use, Diabetes Mellitus, Experimental physiopathology, Diabetic Neuropathies physiopathology, Facial Pain physiopathology, Hyperalgesia physiopathology, Trigeminal Ganglion physiopathology
- Abstract
Peripheral neuropathy is a common complication of diabetes and is often accompanied by episodes of pain. There is evidence that diabetic neuropathy may affect the trigeminal nerve, altering the transmission of orofacial sensory information. Structural changes in the trigeminal ganglia may be involved in the development of these sensory alterations. Herein, we evaluate the development of orofacial sensory changes after streptozotocin-induced diabetes in rats, and their sensitivity to pregabalin and morphine treatments. Furthermore, stereological analysis of the trigeminal ganglia was performed. Diabetic rats showed similar responses to 1% formalin applied into the upper lip compared to normoglycemic rats on weeks 1, 2 and 4 after streptozotocin. Additionally, there was no difference in the facial mechanical threshold of normoglycemic and diabetic rats, on weeks 1 up to 5 after streptozotocin, while the paw mechanical threshold of diabetic rats was significantly reduced. In contrast, diabetic rats developed long-lasting orofacial heat and cold hyperalgesia. Moreover, stereological analyses revealed significant neuronal loss in the trigeminal ganglia of diabetic compared to normoglycemic rats. Pregabalin treatment (30mg/kg, p.o.) of diabetic rats resulted in marked and prolonged (up to 6h) reduction of heat and cold orofacial hyperalgesia. Likewise, morphine treatment (2.5mg/kg, s.c.) abolished orofacial heat and cold hyperalgesia, but its effect was significant only up to 1h after the administration. In conclusion, the results of the present study demonstrated that streptozotocin-treated rats developed long-lasting orofacial heat and cold hyperalgesia, which is more amenable to reduction by pregabalin than morphine., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
50. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
- Author
-
Schreiber AK, Neufeld M, Jesus CH, and Cunha JM
- Subjects
- Animals, Behavior, Animal drug effects, Capsaicin analogs & derivatives, Capsaicin pharmacology, Endocannabinoids pharmacology, Formaldehyde, Hyperalgesia drug therapy, Hyperalgesia etiology, Indoles pharmacology, Male, Pain Measurement drug effects, Rats, Rats, Wistar, Receptors, Cannabinoid drug effects, Analgesics, Arachidonic Acids pharmacology, Diabetes Mellitus, Experimental complications, Diabetic Neuropathies drug therapy, Endocannabinoids physiology, Polyunsaturated Alkamides pharmacology
- Abstract
Diabetes is often associated with painful neuropathy. The current treatments are symptomatic and ineffective. Cannabinoids have been proposed as promising drugs for chronic pain treatment and its antinociceptive effect has already been related in nerve injury models of neuropathic pain, but little has been investigated in painful diabetic neuropathy models. Thus, the current study aims to investigate the potential antinociceptive effect of drugs that alter endocannabinoid system when injected subcutaneously into the dorsal surface of the ipsilateral hind paw in chemical hyperalgesia induced by formalin in both normoglycemic (Ngl) and streptozotocin-diabetic (Dbt) rats. Diabetic rats exhibited exaggerated flinching behaviors during first and second phases of the formalin test, indicating the presence of hyperalgesia. AM404, an anandamide (AEA) re-uptake inhibitor, AEA (an agonist of CB1/CB2 receptors) or ACEA (a selective CB1 receptor agonist) induced antinociception in both phases of formalin test in Ngl and Dbt rats. In both groups, the antinociceptive effect of ACEA was prevented by AM251, a CB1 inverse agonist while the antinociceptive effect of AEA was prevented by AM251 or AM630, a CB2 receptor antagonist. In Ngl rats, the antinociceptive effect of AM404 was prevented by AM251 or capsazepine only during first phase of the formalin test while in Dbt rats, this effect was blocked by pretreatment with AM251 (both phases) or AM630 (second phase). Taken together, these results demonstrated broad-spectrum antinociceptive properties of cannabinoids in a model of painful diabetic neuropathy. Peripheral activation of both cannabinoid receptors seems to mediate the antinociceptive effect of exogenous or endogenous anandamide., (Copyright © 2012 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.